임상 한눈에 보기

• 1건의 ClinicalTrials.gov 임상 기록
• 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
• 모집 중 5건 · 완료/종료 6건
• Phase: PHASE3 · PHASE2 · PHASE1, PHASE2 · NA
• Status: COMPLETED · ACTIVE_NOT_RECRUITING · RECRUITING…
• 주요 endpoint: Percentage of Participants With Invasive Disease-Free Survival (IDFS) Event (Excluding Second Primary Non-Breast Cancer [SPNBC]) · as Assessed Using Radiologic · Histologic Examinations or Laboratory Findings · Kaplan-Meier Estimate of the Percentage of Participants Who Were IDFS Event-Free (Excluding SPNBC) at 3 Years · Kaplan-Meier Estimate of the Percentage of Participants Who Were IDFS Event-Free (Excluding SPNBC) at 6
• 등록 대상자(표본 합산): 약 10,456명
• 선택한 코호트 보고값: ORR 91.8%
• 핵심: This 3 arm study will assess the tolerability, safety and efficacy of 3 neoadjuvant treatment regimens in participants w…

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다. 효능 수치는 선택한 등록 결과이며 전적응증 값이 아닙니다.